SCHEMBL31480801

SCHEMBL31480801

O=C(Cl)OCCN(CC(=O)OCc1ccccc1)C(=O)OCOP(=O)(OCc1ccccc1)OCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.44
▸ MAPK1 P28482 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CCR6 P51684 1/20 0.36
▸ PAX8 Q06710 1/20 0.36
▸ TSHR P16473 1/20 0.35
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ELANE P08246 1/20 0.32
▸ CETP P11597 3/20 0.32
▸ HPGD P15428 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31480709 0.87 CCR6 (0.41) ALDH1A1MAPK1L3MBTL1CCR6PAX8
SCHEMBL31480720 0.86 ALDH1A1 (0.40) ALDH1A1MAPK1L3MBTL1CCR6PAX8
SCHEMBL31480820 0.83 CCR6 (0.41) ALDH1A1MAPK1L3MBTL1CCR6PAX8
SCHEMBL31480857 0.82 BTN3A1 (0.37) ALDH1A1MAPK1L3MBTL1CCR6PAX8
SCHEMBL31480884 0.82 CCR6 (0.42) ALDH1A1MAPK1L3MBTL1CCR6PAX8
SCHEMBL31480877 0.81 HDAC1 (0.37) ALDH1A1MAPK1L3MBTL1TSHRLMNA
SCHEMBL3072372 0.79 ALDH1A1 (0.61) ALDH1A1MAPK1L3MBTL1TSHRLMNA
SCHEMBL31480733 0.78 ALDH1A1 (0.36) ALDH1A1MAPK1L3MBTL1CCR6PAX8
SCHEMBL31480715 0.77 SYK (0.42) MAPK1L3MBTL1CCR6PAX8LMNA
SCHEMBL35211461 0.77 ALDH1A1 (0.64) ALDH1A1MAPK1L3MBTL1CCR6PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025080879-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2025-04-17 — — WO disclosed
US-20250120989-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 2025-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250120989-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF SDHA, SDHB, DPYD ALDH1A1 684/4885MAPK1 4148/4885L3MBTL1 4059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback